Global burden of thrombosis: epidemiologic aspects

AM Wendelboe, GE Raskob - Circulation research, 2016 - Am Heart Assoc
Thromboembolic conditions were estimated to account for 1 in 4 deaths worldwide in 2010
and are the leading cause of mortality. Thromboembolic conditions are divided into arterial …

Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives

Y Béjot, B Daubail, M Giroud - Revue neurologique, 2016 - Elsevier
Because of the growing size and aging of the world's population, the global burden of stroke
is increasing dramatically. Current epidemiological data indicate that 16.9 million people …

[HTML][HTML] Stroke: a global response is needed

W Johnson, O Onuma, M Owolabi… - Bulletin of the World …, 2016 - ncbi.nlm.nih.gov
Stroke: a global response is needed - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

VL Feigin, GA Roth, M Naghavi, P Parmar… - The Lancet …, 2016 - thelancet.com
Background The contribution of modifiable risk factors to the increasing global and regional
burden of stroke is unclear, but knowledge about this contribution is crucial for informing …

Heart disease and stroke statistics—2016 update: a report from the American Heart Association

D Mozaffarian, EJ Benjamin, AS Go, DK Arnett… - circulation, 2016 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Epidemiology of stroke in Europe and trends for the 21st century

Y Béjot, H Bailly, J Durier, M Giroud - La Presse Médicale, 2016 - Elsevier
Despite major improvements in primary prevention and acute treatment over the last
decades, stroke is still a devastating disease. At the beginning of the 21st century, the age …

Efficacy and safety of non-immersive virtual reality exercising in stroke rehabilitation (EVREST): a randomised, multicentre, single-blind, controlled trial

G Saposnik, LG Cohen, M Mamdani… - The Lancet …, 2016 - thelancet.com
Background Non-immersive virtual reality is an emerging strategy to enhance motor
performance for stroke rehabilitation. There has been rapid adoption of non-immersive …

Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study

D Kalladka, J Sinden, K Pollock, C Haig, J McLean… - The Lancet, 2016 - thelancet.com
Background CTX0E03 is an immortalised human neural stem-cell line from which a drug
product (CTX-DP) was developed for allogeneic therapy. Dose-dependent improvement in …

Patient outcomes up to 15 years after stroke: survival, disability, quality of life, cognition and mental health

SL Crichton, BD Bray, C McKevitt, AG Rudd… - Journal of Neurology …, 2016 - jnnp.bmj.com
Background The global epidemiological shift of disease burden towards long-term
conditions means understanding long-term outcomes of cardiovascular disease is …

Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF–TIMI 48 trial

ET Kato, RP Giugliano, CT Ruff… - Journal of the …, 2016 - Am Heart Assoc
Background Elderly patients with atrial fibrillation are at higher risk of both ischemic and
bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE …